SBRT showed improved LPFS over RFA in treating single recurrent small HCC, especially for tumors ≤2 cm. Both SBRT and RFA demonstrated similar PFS, OS, and safety profiles, with mild to moderate side ...
The median radiographic progression-free survival was 4.6 years in patients who received stereotactic body radiotherapy and 2.3 years in patients who did not. Adding metastasis-directed stereotactic ...
SBRT administered to oligometastases was associated with survival benefits in phase 2 trial participants with CRPC receiving abiraterone and ADT. For patients with oligometastatic castrate-resistant ...
In patients with recurrent small hepatocellular carcinoma (HCC), stereotactic body radiotherapy (SBRT) demonstrated superior local progression-free survival (PFS) and tumor control at 3 years compared ...
Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma In this trial, patients with recurrent small HCC (single lesion ≤5 cm) were randomly assigned to receive either SBRT or RFA.
Maastricht, the Netherlands - A new technique using urokinase to liquefy intracerebral hematoma (ICH) followed by stereotactic drainage is safe and produced a "modest" reduction in the amount of ...
Please provide your email address to receive an email when new articles are posted on . The number of facilities prescribing single-fraction lung SBRT is gradually growing, yet primarily at ...
Endoscopic ultrasound-guided fiducial placement has emerged as a critical technique in the optimisation of radiation therapy for pancreatic cancer. Through the use of endoscopic ultrasound (EUS), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results